Q3 update: Novonesis delivers strong Q3 results and now expects full-year organic sales growth at the upper end of 7-8%
07 nov. 2024 02h02 HE
|
Novonesis (Novozymes A/S)
Following increasing demand in the first nine months of the 2024 financial year, Novonesis delivers 9% organic sales growth with a strong 11% organic sales growth in the third quarter. The strong...
Novonesis delivers strong half-year results and increases full-year outlook
27 août 2024 10h34 HE
|
Novozymes A/S
In the first half of 2024, Novonesis delivered 7% organic sales growth with an adjusted EBITDA margin at 35.3%. Following strong first half-year performance, Novonesis increases its full-year organic...
Q1 update: Novonesis delivers 4% organic sales growth in line with expectations and reports progress on the integration
03 mai 2024 01h57 HE
|
Novozymes A/S
For the first quarter as Novonesis, the company delivers 4% organic sales growth in line with expectations. Novonesis maintains the 2024 outlook of 5-7% organic sales growth with an adjusted EBITDA...
The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner
29 janv. 2024 05h27 HE
|
Novozymes A/S
Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis is a world-leading biosolutions partner for...
Novozymes and Chr. Hansen announce name of future combined company; Novonesis
13 déc. 2023 01h59 HE
|
Novozymes A/S
Novozymes and Chr. Hansen have announced that the name of the future combined company will be ‘Novonesis’. Novonesis means ‘A new beginning’ and derives from the Greek word ‘genesis’. The name...
Novozymes accelerates growth in Q3 and is on track to deliver on full-year expectations
26 oct. 2023 02h01 HE
|
Novozymes A/S
After the first nine months of the 2023 financial year, Novozymes sees increasing demand for sustainable biosolutions and delivers 5% organic sales growth. The full-year organic sales growth outlook...
Novozymes launches new biosolution to redefine the plant-based meat experience by enhancing texture and encouraging more consumers to choose plant-based alternatives
28 sept. 2023 02h48 HE
|
Novozymes A/S
Novozymes is excited to offer Vertera® ProBite as a game-changing solution to the plant-based meat industry, opening up new possibilities to create today's and tomorrow's plant-based meat products...
Novozymes and Bactolife join forces to significantly reduce post weaning diarrhea and antibiotic use among weaner pigs
04 sept. 2023 03h07 HE
|
Novozymes A/S
The two companies have signed a joint development and commercialization agreement to launch feed additive Ablacto+. The game changing biosolution uses binding proteins to stabilize the gut of...
Novozymes delivers results within expectations in the first half of 2023 and narrows the full year outlook
09 août 2023 01h59 HE
|
Novozymes A/S
After the first half of 2023, Novozymes sees overall stability in a volatile environment and delivers 3% organic sales growth. Following destocking and lower consumer demand, the organic full-year...
Novozymes delivers historically strong full-year results
26 janv. 2023 02h01 HE
|
Novozymes A/S
Novozymes is delivering strong growth and earnings in a volatile market environment with 9% organic sales growth in 2022. This marks the highest organic sales growth in more than a decade, and...